UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report: February 12, 2020
PURE HARVEST CANNABIS GROUP, INC.
--------------------------------------------
(Name of registrant as specified in its charter)
Colorado 333-212055 71-0942431
--------------------- ------------------ ------------------------------
State of Incorporation Commission File No. IRS Employer Identification No.
2401 E. 2nd Avenue, Suite 600
Denver, CO 80206
--------------------------
Address of principal executive offices
(800) 924-3716
--------------------
Telephone number, including area code
Former name or former address if changed since last report
Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any of the
following provisions:
[ ] Written communications pursuant to Rule 425 under the Securities Act
(17 CFR 230.425)
[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act
(17 CFR 240.14a-12)
[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the
Exchange Act (17 CFR 240.14d-2(b))
[ ] Pre-commencement communications pursuant to Rule 13e-14(c) under the
Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each class Trading Symbol Name of each exchange on which registered
------------------- -------------- -----------------------------------------
None N/A N/A
Indicate by check mark whether the Registrant is an emerging growth company as
defined in Rule 405 of the Securities Act of 1933 (230.405 of this chapter) or
Rule 12b-2 of the Securities Exchange Act of 1934 (240.12b-2 of this chapter).
Emerging Growth Company [x]
If an emerging growth company, indicate by check mark if the Registrant has
elected not to use the extended transition period for complying with any new or
revised financial accounting standards provided pursuant to Section 13a of the
Exchange Act. [x]
Item 8.01 Other Events
On February 12, 2020, the Company entered into an Operating Agreement with
Dr. James Rouse, N.M.D. regarding the ownership, operation, and management of
Love Pharm, LLC. Love Pharm was organized to formulate, develop, manufacture,
and brand hemp/CBD products for sale and distribution as well as to form a
multi-channel media platform for public and patient education regarding the
endocannabinoid system utilizing Dr. Rouse's name, public image and his
extensive experience and expertise in medicine and entrepreneurship. Under the
Operating Agreement between the Company and Dr. Rouse, the Company owns 51% of
Love Pharm and has a right of first refusal to purchase the remaining 49% of
Love Pharm from Dr. Rouse. Additionally, Dr. Rouse will be added to the
Company's Advisory Board as the Health, Wellness & Lifestyle Advisor. Dr. Rouse
will receive 100,000 shares of the Company's common stock for services provided
to the Company. As of May 18, 2020, Love Pharm is in the process of product
creation and had not generated any revenue.
2
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant caused this report to be signed on its behalf by the undersigned,
thereunto duly authorized.
May 18, 2020.
PURE HARVEST CANNABIS GROUP, INC.
By: /s/ Matthew Gregarek
--------------------------------
Matthew Gregarek
Chief Executive Officer
3